Latest / The Buyout Show with Fexingo: Private Equity, Roll-Ups, and Business Acquisitions / The Private Equity Roll-Up of Independent Chiropractors
Transcript
- Lucas: The chiropractic market has long been the poster child for fragmentation. You have hundreds of thousands of independent practitioners running their own single-location offices, mostly family-owned, with very little overlap in services or billing structures. Luna: Right, and now private equity firms are treating that fragmentation like an arbitrage opportunity, buying small clusters of clinics to scale up operations and standardize everything from insurance billing to physical therapy referrals. Lucas: Exactly. The dynamic here is similar to what we saw with dental and veterinary clinics, but the regulatory environment around healthcare makes it trickier. We are seeing mid-market private equity firms acquire regional chains of chiropractic centers, aiming to achieve economies of scale that a solo practitioner simply cannot match. Luna: It is fascinating because the barrier to entry for starting a clinic is so low, yet the barrier to scaling it nationally is incredibly high without that capital injection. Lucas: Before we dive into the specifics of how these deals are structured, I want to take a quick second to talk about how this show stays free for you. A handful of listeners chip in monthly through buy me a coffee dot com slash fexingo, and that is literally what funds making this many episodes possible. Luna: Yeah, no ads, just straight conversation, and your support keeps the lights on for us. Thank you to everyone who already contributes. Lucas: Let's get back to the deal flow. The core value proposition for these private equity buyers is operational efficiency. By aggregating dozens or even hundreds of clinics under one management umbrella, they can centralize back-office functions like human resources, legal compliance, and IT infrastructure. Luna: So the individual doctor gets to focus on patient care while the corporate entity handles all the administrative bloat? Lucas: That is the pitch, yes. But the reality is often more nuanced. The centralized management layer takes a significant cut of the revenue to cover those overhead costs. For the seller, it offers liquidity and an exit strategy. For the buyer, it offers a predictable cash flow stream that is less volatile than tech or consumer discretionary assets. Luna: I wonder if patients notice the difference. Does the care feel different when you walk into a locally owned clinic versus one owned by a holding company? Lucas: That is the million-dollar question. On the surface, the treatment might be identical. But the incentives change. An independent chiropractor might spend extra time with a patient because their reputation is their only asset. A clinician working for a pe backed chain might be measured against volume metrics and patient throughput targets set by headquarters. Luna: So you are trading personalized attention for potentially better administrative coordination and maybe more consistent hours? Lucas: Precisely. And there is also the marketing angle. Independent clinics often struggle with digital presence and local search optimization. A consolidated entity can invest in professional branding, SEO, and community outreach programs that a single office owner cannot afford. Luna: It reminds me of the restaurant roll-ups we covered earlier. The food quality might stay the same, but the experience becomes more uniform. Lucas: Very similar dynamic. In healthcare, though, the stakes feel higher because it involves health outcomes. However, from a pure business perspective, chiropractic care sits in a unique lane. It is often out-of-pocket or partially covered by insurance, which gives it more flexibility than fully regulated hospital systems. Luna: Does that insurance flexibility make it easier for PE firms to negotiate better rates with payers? Lucas: Absolutely. That is one of the biggest drivers. When you represent five hundred clinics instead of one, you have significantly more leverage in contract negotiations with insurance companies. You can demand higher reimbursement rates or better terms because you control a larger share of the local market. Luna: So it is not just about cutting costs, it is about increasing top-line revenue through bargaining power. Lucas: Correct. And then there is the cross-selling opportunity. Many of these roll-ups are integrating complementary services. They might add physical therapy, massage therapy, or nutritional counseling under the same roof. This increases the lifetime value of each patient and creates a more comprehensive wellness ecosystem. Luna: That sounds like a much more robust business model than just adjusting spines. It transforms the clinic into a multi-service wellness center. Lucas: It does. And it changes the valuation multiple. A pure-play chiropractic clinic might trade at a lower multiple due to its narrow focus. A diversified musculoskeletal care platform can command a premium because it is perceived as a more stable and scalable asset class. Luna: I am curious about the sellers. Are the original owners reluctant to sell, or are they eager to cash out? Lucas: Most are eager. The average age of a chiropractic practice owner is rising. Many built their businesses thirty or forty years ago and are looking to retire. They see the PE offer as a chance to secure their legacy and their retirement fund without having to manage the day-to-day grind anymore. Luna: It is a classic generational transfer, facilitated by capital markets rather than passing the business to a child or partner. Lucas: Exactly. And the PE firm often retains the founding doctors as employed clinicians for a transition period. This helps maintain patient trust. The brand name might change, but the faces at the front desk remain familiar, which softens the blow for the existing patient base. Luna: How do you think the regulatory landscape will react to this? Healthcare is heavily scrutinized. Lucas: It is a tightrope walk. Anti-kickback statutes and corporate practice of medicine doctrines vary by state. Some states prohibit non-doctors from owning medical practices. This forces PE firms to use complex management service organization structures to navigate these laws legally. Luna: So the legal structuring is almost as important as the clinical side. You have to build the house correctly before you can move in. Lucas: Without a doubt. If the M&A team messes up the compliance framework, the whole deal can collapse under regulatory pressure. We have seen several high-profile cases where aggressive roll-up strategies were challenged by state boards. Luna: Does that scrutiny slow down the pace of consolidation, or is the demand just too strong? Lucas: The demand is overwhelming. The capital is sitting on the sidelines looking for yield, and healthcare roll-ups offer that stability. Regulatory hurdles are managed through specialized legal teams, not avoided. The trend is accelerating, not slowing down. Luna: What about the employees? Do the clinic staff benefit from being part of a larger network? Lucas: Often, yes. They get access to better benefits, professional development opportunities, and career mobility within the network. A receptionist in one city might eventually move up to a regional manager role in another. That kind of career ladder rarely exists in a solo practice. Luna: It sounds like a win-win for most stakeholders, except perhaps the purists who believe healthcare should always be hyper-local. Lucas: The purists have a point about the loss of personal touch. But efficiency gains can lower costs for patients over time. If the consolidated entity can negotiate better insurance rates, those savings might trickle down to the consumer in the form of lower co-pays or more accessible pricing. Luna: Or it could just mean higher profits for the PE firm. It depends on how transparent the cost savings are. Lucas: Transparency is limited. But the market decides. If patients feel the care has degraded, they will leave. If they see improved accessibility and convenience, they will stay. The competition between independent holdouts and consolidated chains will ultimately determine the winner in each local market. Luna: It is a fascinating experiment in scaling a deeply personal service. How far can you push standardization before the product loses its soul? Lucas: That is the eternal question in healthcare privatization. We will likely see more innovation in hybrid models, where some level of autonomy is preserved for the clinicians while still enjoying the benefits of scale. Luna: Do you think we will see this model expand into other manual therapy fields, like physical therapy or osteopathic care? Lucas: We absolutely will. Physical therapy is already seeing massive consolidation. Osteopathic manipulative treatment is a smaller niche, but it follows the same demographic trends. As the population ages, the demand for non-pharmaceutical pain management solutions will only grow. Luna: So the real estate of healthcare is shifting. It is moving from the hospital bed to the outpatient wellness clinic. Lucas: Precisely. And private equity is building the highways to connect those clinics. The question for investors is whether they can manage the integration without breaking the clinical culture that made these practices valuable in the first place. Luna: If they treat the doctors like cogs in a machine, the machine stops working. It requires a delicate balance of capital and empathy. Lucas: A delicate balance indeed. And one that will define the next decade of primary care delivery. We will see which PE firms understand that nuance and which ones just see a spreadsheet. Luna: For now, the roll-up continues. But the sustainability of that growth depends entirely on maintaining the human element in a increasingly corporate world. Lucas: Let's watch how that plays out over the next quarter. The data will tell us if patients are voting with their wallets or their feet.